From @jaccjournals https://t.co/IUlOS6L4JL good reminder that risk of endocarditis is about 5% and occurs about a year after AVR. Males with CKD more at risk. Similar risk between TAVR and SAVR. Danish study
New2Trip: Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement https://t.co/rWXWgFfNch
Good cohort study: 2,632 TAVR pts & 3,777 surgical pts, 3.6yr mean follow-up. No diff. in 1yr & 5yr incidence of IE (~2% & ~5%, respectively). https://t.co/0TKqZzfe2u
New2Trip: Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement https://t.co/rWXWgFfNch
RT @CarlesFalces: La incidencia de endocarditis infecciosa en pacientes tras implante de #TAVI es de 5,8% a los 5 años, muy similar a la de…
RT @CarlesFalces: La incidencia de endocarditis infecciosa en pacientes tras implante de #TAVI es de 5,8% a los 5 años, muy similar a la de…
La incidencia de endocarditis infecciosa en pacientes tras implante de #TAVI es de 5,8% a los 5 años, muy similar a la de los pacientes tras sustitución valvular aórtica quirúrgica #TAVR #EndocarditisTeam @JACCJournals @SociedadSEICAV https://t.co/mhL
RT @keita_masui: 今年3月のPARTNER3試験から、手術リスクが低い患者でも、術後成績は #TAVI > #SAVR であることが判明 DOI: 10.1056/NEJMoa1814052 https://t.co/Nhv4mP57Ux #QALY の議論が…
今年3月のPARTNER3試験から、手術リスクが低い患者でも、術後成績は #TAVI > #SAVR であることが判明 DOI: 10.1056/NEJMoa1814052 https://t.co/Nhv4mP57Ux #QALY の議論がされていますが、デバイスの価格(現在約440万円)が今後の普及課題かと思われます https://t.co/1LLwUxsspv | @NMonl
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
#TAVI と #SAVR とのあいだでの心内膜炎(IE)のリスクの有意差無しとの報告 SAVRのIEリスクが相対的に高いと考えられていた点がTAVI推進のドライバーだったとすると、待ったが掛かった状況 https://t.co/yWs3a4gMUv | @JACCJournals https://t.co/o8swT3cRWK | @NMonl
Observational cohort study examines risk of infective endocarditis in all patients undergoing TAVR versus isolated SAVR. Results show the 5-year incidence following TAVR was 5.8%, which is not significantly different than the incidence following SAVR.https
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
Riesgo de endocarditis a largo plazo, TAVR vs SAVR. Información importante y que faltaba. Se hace la misma profilaxis que el reemplazo convencional? https://t.co/UFDeCPacB6 #Cardiology @SACemergencias @SAC_54 @hemodinamiasac @CECICath @CACIarg
RT @JACCJournals: What is the long-term risk of infective #endocarditis after #TAVR? Read more in #JACC. https://t.co/1OgjUljNRi https://t.…
RT @JACCJournals: What is the long-term risk of infective #endocarditis after #TAVR? Read more in #JACC. https://t.co/1OgjUljNRi https://t.…
RT @JACCJournals: What is the long-term risk of infective #endocarditis after #TAVR? Read more in #JACC. https://t.co/1OgjUljNRi https://t.…
RT @JACCJournals: What is the long-term risk of infective #endocarditis after #TAVR? Read more in #JACC. https://t.co/1OgjUljNRi https://t.…
RT @JACCJournals: What is the long-term risk of infective #endocarditis after #TAVR? Read more in #JACC. https://t.co/1OgjUljNRi https://t.…
What is the long-term risk of infective #endocarditis after #TAVR? Read more in #JACC. https://t.co/1OgjUljNRi https://t.co/R5vWBCQoqE
RT @JACCJournals: Danish observational cohort study examines the risk of infective endocarditis in all patients undergoing #TAVR versus iso…
RT @JACCJournals: Danish observational cohort study examines the risk of infective endocarditis in all patients undergoing #TAVR versus iso…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @JACCJournals: Danish observational cohort study examines the risk of infective endocarditis in all patients undergoing #TAVR versus iso…
RT @JACCJournals: Danish observational cohort study examines the risk of infective endocarditis in all patients undergoing #TAVR versus iso…
RT @JACCJournals: Danish observational cohort study examines the risk of infective endocarditis in all patients undergoing #TAVR versus iso…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
Extremely interesting study focus. I'm curious to discover whether the 3VB 3C protease is required for the same viral replication seen in endocarditis as it is for myocarditis. #biom4180
RT @JACCJournals: Danish observational cohort study examines the risk of infective endocarditis in all patients undergoing #TAVR versus iso…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @JACCJournals: Danish observational cohort study examines the risk of infective endocarditis in all patients undergoing #TAVR versus iso…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @JACCJournals: Danish observational cohort study examines the risk of infective endocarditis in all patients undergoing #TAVR versus iso…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
Danish observational cohort study examines the risk of infective endocarditis in all patients undergoing #TAVR versus isolated #SAVR. https://t.co/ta2FKXHcR2 #JACC https://t.co/VRNo0T5Suv
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
Risk of endocarditis in TAVR = risk of emdocarditis in SAVR.
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
RT @Steph_Achenbach: Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgic…
Risk of endocarditis 5.8% over 5 years following TAVI/TAVR - after adjustment, not significantly different from surgical aortic valve replacement. Danish cohort study of 6409 patients in JACC https://t.co/fOfH0ZBQuB #CardioTwitter @escardio #TAVR https://t
【TAVI後長期観察もIEリスク増は認めず/ JACC】 デンマーク全国レジストリ、TAVI施行2632例 vs. SAVRの3777例:平均3.6年観察後、感染性心内膜炎発生率はTAVIで4.4%、SAVRが4.9%。多変量解析後TAVIによるIEのHRは1.12 [95%CI 0.84-1.49]。 https://t.co/vbR7QA158j https://t.co/vyEFtHqmKT
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
#EAPCI @secardiologia @shci_sec
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
RT @gonzaeperez: ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals ht…
ENDOCARDITIS INFECCIOSA EN #TAVR A 5 años la incidencia es de 5.8% en TAVR, sin diferencias vs #SAVR Vía @JACCJournals https://t.co/INXDqDpfXe https://t.co/TMYrWxuPK5
Similar rates of infective endocarditis after TAVR and SAVR. Pretty interesting data and reassuring to know. https://t.co/v482vyG1Yb https://t.co/2qIVgs1a1d